The role of TPSA, IGF-1 and IGFBP-3, values in the distinctive diagnosis of benign prostate hyperplasia and prostate cancer.

被引：0
|
作者：
Kaya, H.
Sucu, I.
Tuzcu, S. Altun
Ar, S.
Sahin, H.
机构：
[1] Dicle Univ, Sch Med, Dept Nucl Med, Diyarbakir, Turkey
[2] Dicle Univ, Sch Med, Dept Urol, Diyarbakir, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [1] Diagnostic value of IGF-1 and IGFBP-3 in prostate cancer and benign prostate hyperplasia
    Kaya, H.
    Altunci, G. Kaya
    Ar, S.
    Dag, Y.
    Gedik, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S233 - S233
  • [2] The role of IGF-1 and IGFBP-3 in predicting disease progression in Prostate Cancer patients
    Siabanopoulou, M. T.
    Iakovou, I.
    Zaromitidou, E.
    Ordoulidis, S. El Mantani
    Galaktidou, G.
    Dimasis, N.
    Sioundas, A.
    Gotzamani-Psarrakou, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S576 - S576
  • [3] Relation of plasma IGF-1 and IGFBP-3 to the risk of prostate cancer
    Woongeol, Y.
    Kwanjin, P.
    Seong Jin, J.
    Eunsik, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 149 - 149
  • [4] IGF-1, IGFBP-3, and cancer risk
    Holly, J
    LANCET, 2004, 364 (9431): : 325 - 326
  • [5] Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
    Wolk, A
    Andersson, SO
    Mantzoros, CS
    Trichopoulos, D
    Adami, HO
    LANCET, 2000, 356 (9245): : 1902 - 1903
  • [6] IGF-1 and IGFBP-3: Risk of prostate cancer among men in the prostate, lung, colorectal and ovarian cancer screening trial
    Weiss, Jocelyn M.
    Huang, Wen-Yi
    Rinaldi, Sabina
    Fears, Thomas R.
    Chatterjee, Nilanjan
    Chia, David
    Crawford, E. David
    Kaaks, Rudolf
    Hayes, Richard B.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) : 2267 - 2273
  • [7] Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication
    Raval, Apexa
    Trivedi, Sunil
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2016, 54 (10) : 619 - 629
  • [8] The significance of PSA/IGF-1 ratio in differentiating benign prostate hyperplasia from prostate cancer
    Koliakos, G
    Chatzivasiliou, D
    Dimopoulos, T
    Trachana, V
    Paschalidou, K
    Galiamoutsas, V
    Triantos, A
    Chitas, G
    Dimopoulos, A
    Vlatsas, G
    DISEASE MARKERS, 2000, 16 (3-4) : 143 - 146
  • [9] IGFBP-3 Is a Metastasis Suppression Gene for Prostate Cancer.
    Mehta, H. H.
    Cobb, L. J.
    Said, J.
    Lee, A.
    Dong, D.
    Lee, K. W.
    Cohen, P.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [10] Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
    Protopsaltis, Ioannis
    Ploumidis, Achilles
    Sergentanis, Theodoros N.
    Constantoulakis, Padelis
    Tzirogiannis, Kostantinos
    Kyprianidou, Chrysoula
    Papazafiropoulou, Athanasia K.
    Melidonis, Andreas
    Delakas, Dimitrios
    PLOS ONE, 2013, 8 (12):
12345